Navigation Links
MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
Date:11/17/2011

DALLAS, November 17, 2011 /PRNewswire/ --

The report "Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast) [http://www.marketsandmarkets.com/Market-Reports/prostate-cance-drugs-market-413.html]", as the name suggests, analyzes and studies the major market drivers, restraints, and opportunities in North America (U.S. & Canada), Europe (Germany, France, U.K., Italy, and Spain) and emerging markets (Brazil, India, China, Russia, Turkey, and South Korea).

Browse market data tables and in-depth TOC on Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast).
http://www.marketsandmarkets.com/Market-Reports/prostate-cance-drugs-market-413.html
Early buyers will receive 10% customization on reports.

The prostate is an exocrine gland found in men, located in the groin area just below the bladder and in front of the rectum. In prostate cancer, cells within the gland mutate into cancer cells. Further, these affected cells start killing the other healthy gland cells, and can spread to the other body parts. Prostate cancer is the second leading cause of new cancer cases in men worldwide and the sixth leading cause of cancerous death in men. Globally, about 899,000 men were diagnosed with prostate cancer in 2008 and it is estimated that this number will get doubled (1.7 million) by 2030.

Global prostate cancer therapeutics market [ http://www.marketsandmarkets.com/Market-Reports/prostate-cance-drugs-market-413.html ] was valued at $2,713 million in 2010 and it is expected to reach $6,457 million, by 2020. It is estimated that the market will grow at a CAGR of 11.4% and 6.8% from 2010 to 2015 and 2015 to 2020 respectively. By therapy, hormonal therapy is dominating the global prostate cancer drugs market with 66% market share in 2010 and expected to account for 53% market share in 2020. However, by 2020, immunotherapy and targeted therapy will significantly gain market share due to advantages such as increase in the overall survival and progression free survival with benign side effects profile.

In 2010, Europe dominated the global prostate cancer drug market by accounting to 43% market share; followed by Europe is North America with the share of 42%.

The major players in the market as of 2010 include AstraZeneca PLC (U.K.), Sanofi-Aventis (France), Ipsen (France), Tolmar Inc (U.S.), Abbott (U.S.), Astellas Pharma Inc (Japan), Indevus Pharmaceuticals Inc (U.S.), Dendreon Corporation (U.S.), and Ferring Pharmaceuticals (Switzerland).

Other Reports by MarketsandMarkets


Upcoming Market Research by MarketsandMarkets


About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical, pharmaceuticals [ http://www.marketsandmarkets.com/pharmaceutical-market-research-3.html ], semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com.

Contact:
Mr. Rohan
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com
MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/
http://twitter.com/marketsmarkets



'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014
2. MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014
3. Marketsandmarkets: Global Minimally Invasive/ Non Invasive Market Worth $24.4 Billion by 2014
4. MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014
5. MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014
6. MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014
7. MarketsandMarkets: Global Biochip (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Market to Reach $5.6 Billion by 2015
8. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
9. Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
10. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
11. Forward step in forecasting global warming
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016 Q BioMed Inc. ... CEO  was featured in an article he wrote ... Fear To Tread: http://www.lifescienceleader.com/doc/accelerators-enter-when-vcs-fear-to-tread-0001 ... is an essential business journal for life science ... to Big Pharmas. Their content is designed to ...
(Date:4/27/2016)... ... April 27, 2016 , ... Cambridge Semantics, the leading provider ... announced that it has been named to The Silicon Review’s “20 Fastest Growing Big ... markets, Cambridge Semantics serves the needs of end users facing some of the most ...
(Date:4/27/2016)... and RESEARCH TRIANGLE PARK, N.C. ... (NASDAQ: UTHR ) announced today that ... of United Therapeutics will provide an overview and update ... st Annual Health Care Conference. The ... at 10:00 a.m. Eastern Time, and can be accessed ...
(Date:4/27/2016)... ... ... Global Stem Cells Group CEO Benito Novas announced that Duncan ... affiliate Kimera Labs in Miami. , In 2004, Ross received his Ph.D. in Immunology ... disorders and the suppression of graft vs. host disease (GVHD) under UM Professor Robert ...
Breaking Biology Technology:
(Date:3/15/2016)... 15, 2016 --> ... Transparency Market Research "Digital Door Lock Systems Market - Global ... 2023," the global digital door lock systems market in terms ... and is forecast to grow at a CAGR of 31.8% ... and medium enterprises (MSMEs) across the world and high industrial ...
(Date:3/14/2016)... , March 14, 2016 NXTD ... growing mobile commerce market, announces the airing of a new ... starting the week of March 21 st .  The commercials ... including its popular Squawk on the Street show. --> ... on the growing mobile commerce market, announces the airing of ...
(Date:3/11/2016)... http://www.apimages.com ) - --> http://www.apimages.com ) - ... Images ( http://www.apimages.com ) - Germany . ... new refugee identity cards. DERMALOG will be unveiling this device, and ... Hanover next week.   --> Germany ... the new refugee identity cards. DERMALOG will be unveiling this device, ...
Breaking Biology News(10 mins):